Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evotec AG - 26 Year Stock Price History | EVO

Historical daily share price chart and data for Evotec AG since 1999 adjusted for splits and dividends. The latest closing stock price for Evotec AG as of February 14, 2025 is 4.58.
  • The all-time high Evotec AG stock closing price was 25.10 on December 15, 2021.
  • The Evotec AG 52-week high stock price is 7.98, which is 74.2% above the current share price.
  • The Evotec AG 52-week low stock price is 2.85, which is 37.8% below the current share price.
  • The average Evotec AG stock price for the last 52 weeks is 4.85.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Evotec AG Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 4.3510 4.2700 4.7100 4.0400 4.5800 10.10%
2024 5.3794 11.4000 11.4000 2.9000 4.1600 -64.54%
2023 10.4506 8.1500 13.3600 8.1100 11.7300 44.99%
2022 12.6889 23.4600 23.4600 7.8000 8.0900 -65.94%
2021 23.3321 22.5500 25.1000 22.3200 23.7500 0.00%
2019 12.5493 12.2700 12.6500 12.2700 12.6200 4.55%
2018 12.1130 12.4148 12.6039 11.5864 12.0711 -2.68%
2017 12.7728 12.5613 13.3764 12.2853 12.4036 0.09%
2016 13.3157 12.4136 14.5444 12.2972 12.3924 1.32%
2015 11.5921 11.3435 12.3700 11.1549 12.2304 8.45%
2014 10.7777 9.4872 11.3352 9.4872 11.2773 18.77%
2013 10.2233 12.5134 12.7211 8.9044 9.4950 -22.14%
2012 11.1421 9.7447 13.0121 9.7447 12.1947 25.41%
2011 8.7632 8.1738 9.8290 7.5303 9.7237 18.46%
2010 8.7726 8.2163 9.9374 7.9456 8.2083 -0.31%
2009 7.1686 5.2842 8.8174 5.2842 8.2335 62.17%
2008 6.4757 6.9636 7.5280 4.2029 5.0772 -27.09%
2007 7.5166 7.6141 8.1318 6.7846 6.9636 -8.61%
2006 7.3563 7.2246 7.6816 7.0408 7.6193 6.33%
2005 7.4262 7.6184 8.0385 6.7535 7.1654 -6.58%
2004 7.1711 6.9077 7.8607 6.0584 7.6697 10.13%
2003 6.6042 6.4536 7.1532 6.0521 6.9645 9.59%
2002 5.9360 5.0603 6.6881 5.0603 6.3552 25.88%
2001 4.8892 4.2938 5.3179 4.2938 5.0488 19.40%
2000 4.0406 3.6549 4.3411 3.6506 4.2283 17.78%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.623B $0.846B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $77.932B 30.75
Zoetis (ZTS) United States $70.536B 26.61
Daiichi Sankyo, - (DSNKY) $45.590B 27.78
Takeda Pharmaceutical (TAK) Japan $43.083B 9.54
Sandoz Group AG (SDZNY) Switzerland $21.859B 0.00
Merck (MKKGY) Germany $18.359B 16.44
Astellas Pharma (ALPMY) Japan $17.680B 12.53
United Therapeutics (UTHR) United States $16.544B 16.27
Summit Therapeutics (SMMT) United States $15.759B 0.00
Shionogi (SGIOY) Japan $12.012B 12.03
Neurocrine Biosciences (NBIX) United States $11.468B 34.96
Corcept Therapeutics (CORT) United States $7.619B 57.71
Orion OYJ (ORINY) Finland $7.614B 21.41
Madrigal Pharmaceuticals (MDGL) United States $7.354B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.245B 0.00
Stevanato Group S.p.A (STVN) Italy $5.918B 38.31
Grifols, S.A (GRFS) Spain $5.033B 0.00
Ionis Pharmaceuticals (IONS) United States $4.901B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.650B 9.52
Recursion Pharmaceuticals (RXRX) United States $4.114B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.265B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.775B 12.58
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.395B 14.31
Centessa Pharmaceuticals (CNTA) United Kingdom $2.251B 0.00
Hypermarcas (HYPMY) Brazil $2.179B 0.00
Soleno Therapeutics (SLNO) United States $2.120B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.875B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.839B 0.00
Dyne Therapeutics (DYN) United States $1.416B 0.00
Ardelyx (ARDX) United States $1.371B 0.00
Indivior (INDV) United States $1.355B 5.52
Guardian Pharmacy Services (GRDN) United States $1.250B 0.00
ARS Pharmaceuticals (SPRY) United States $1.168B 0.00
Ocular Therapeutix (OCUL) United States $1.145B 0.00
Xencor (XNCR) United States $1.141B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.115B 0.00
Harrow (HROW) United States $1.083B 0.00
Enliven Therapeutics (ELVN) United States $1.059B 0.00
Collegium Pharmaceutical (COLL) United States $0.957B 5.22
Bioventus (BVS) United States $0.845B 26.69
Avadel Pharmaceuticals (AVDL) Ireland $0.830B 0.00
Cronos Group (CRON) Canada $0.754B 0.00
Verve Therapeutics (VERV) United States $0.726B 0.00
Relay Therapeutics (RLAY) United States $0.670B 0.00
USANA Health Sciences (USNA) United States $0.604B 11.20
Elite Pharmaceuticals (ELTP) United States $0.566B 0.00
OmniAb (OABI) United States $0.538B 0.00
Xeris Biopharma Holdings (XERS) United States $0.535B 0.00
Savara (SVRA) United States $0.484B 0.00
KalVista Pharmaceuticals (KALV) United States $0.482B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.473B 0.00
ProKidney (PROK) United States $0.470B 0.00
Organogenesis (ORGO) United States $0.465B 0.00
Akebia Therapeutics (AKBA) United States $0.465B 0.00
Altimmune (ALT) United States $0.453B 0.00
Siga Technologies (SIGA) United States $0.438B 5.12
Zevra Therapeutics (ZVRA) United States $0.431B 0.00
Oruka Therapeutics (ORKA) United States $0.391B 0.00
Aldeyra Therapeutics (ALDX) United States $0.386B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.380B 154.07
Esperion Therapeutics (ESPR) United States $0.366B 0.00
Tourmaline Bio (TRML) United States $0.355B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.307B 0.00
Aquestive Therapeutics (AQST) United States $0.303B 0.00
Korro Bio (KRRO) United States $0.281B 0.00
Avita Medical (RCEL) United States $0.277B 0.00
Heron Therapeutics (HRTX) United States $0.271B 0.00
Nature's Sunshine Products (NATR) United States $0.268B 15.94
CytoDyn (CYDY) United States $0.267B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.255B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
4D Molecular Therapeutics (FDMT) United States $0.226B 0.00
Larimar Therapeutics (LRMR) United States $0.213B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Profound Medical (PROF) Canada $0.201B 0.00
Nanobiotix S.A (NBTX) France $0.190B 0.00
Nektar Therapeutics (NKTR) United States $0.181B 0.00
Lyell Immunopharma (LYEL) United States $0.178B 0.00
VAXART, INC (VXRT) United States $0.170B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.169B 0.00
Acrivon Therapeutics (ACRV) United States $0.169B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Inhibikase Therapeutics (IKT) United States $0.163B 0.00
Champions Oncology (CSBR) United States $0.153B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.152B 0.00
Lexeo Therapeutics (LXEO) United States $0.149B 0.00
Silence Therapeutics (SLN) United Kingdom $0.145B 0.00
Telomir Pharmaceuticals (TELO) United States $0.128B 0.00
Inotiv (NOTV) United States $0.127B 0.00
Achieve Life Sciences (ACHV) Canada $0.118B 0.00
Cassava Sciences (SAVA) United States $0.116B 0.00
ElectroCore (ECOR) United States $0.116B 0.00
Journey Medical (DERM) United States $0.109B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Metagenomi (MGX) United States $0.098B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Protara Therapeutics (TARA) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Assertio Holdings (ASRT) United States $0.080B 21.04
Regulus Therapeutics (RGLS) United States $0.079B 0.00
Nutriband (NTRB) United States $0.079B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
Karyopharm Therapeutics (KPTI) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Avalo Therapeutics (AVTX) United States $0.076B 0.00
Fractyl Health (GUTS) United States $0.076B 0.00
Dominari Holdings (DOMH) United States $0.076B 0.00
Mural Oncology (MURA) Ireland $0.073B 0.00
Gain Therapeutics (GANX) United States $0.072B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
AleAnna (ANNA) United States $0.068B 0.00
Century Therapeutics (IPSC) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
Unicycive Therapeutics (UNCY) United States $0.061B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.060B 0.00
FibroGen (FGEN) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Iterum Therapeutics (ITRM) Ireland $0.053B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
AlloVir (ALVR) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
SCYNEXIS (SCYX) United States $0.043B 0.00
Tempest Therapeutics (TPST) United States $0.041B 0.00
CASI Pharmaceuticals (CASI) China $0.039B 0.00
Surrozen (SRZN) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
BioVie (BIVI) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
Incannex Healthcare (IXHL) Australia $0.031B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Scienture Holdings (SCNX) United States $0.028B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.024B 0.00
Vivos Therapeutics (VVOS) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Traws Pharma (TRAW) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.022B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
Lipocine (LPCN) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Biomerica (BMRA) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Mangoceuticals (MGRX) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Klotho Neurosciences (KLTO) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
ProPhase Labs (PRPH) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
CERo Therapeutics Holdings (CERO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00